Aaltomaa S, Lipponen P, Papinaho S, Kosma V M
Department of Surgery, University of Kuopio, Finland.
Anticancer Res. 1993 May-Jun;13(3):785-8.
The number of stromal mast cells was counted in 187 breast carcinomas. The number of mast cells/mm2 of tumour stroma was studied in relation to clinical, histological and quantitative prognostic factors and survival. A high number of mast cells in tumour stroma was significantly related to low S phase fraction (p = 0.001), DNA diploidy (p = 0.028), high proportion of intraductal growth (p = 0.003) and high degree of tubule formation (p = 0.044). Large tumours showed a lower number of mast cells in stroma (p = 0.08). A non-significant trend was found between mast cell count and axillary lymph node status, sex steroid receptor content, histological type, morphometric nuclear factors and mitotic frequency. In survival analysis a high mast cell count (over 10 g per mm2 of tumour stroma) was related to a favorable prognosis (p = 0.04). The present results confirm previous results in that changes in mast cell count are related to histopathological characteristics and clinical outcome in breast cancer.
对187例乳腺癌的间质肥大细胞进行计数。研究肿瘤间质中肥大细胞数/mm²与临床、组织学及定量预后因素和生存率之间的关系。肿瘤间质中大量肥大细胞与低S期分数(p = 0.001)、DNA二倍体(p = 0.028)、导管内生长的高比例(p = 0.003)和高程度的小管形成(p = 0.044)显著相关。大肿瘤的间质中肥大细胞数量较少(p = 0.08)。在肥大细胞计数与腋窝淋巴结状态、性类固醇受体含量、组织学类型、形态计量核因子和有丝分裂频率之间发现了不显著的趋势。在生存分析中,高肥大细胞计数(每mm²肿瘤间质超过10g)与良好的预后相关(p = 0.04)。目前的结果证实了先前的结果,即肥大细胞计数的变化与乳腺癌的组织病理学特征和临床结果相关。